We found that lung cancer (TCGA-LUAD) exhibits a much higher enrichment score and pathway activity for genes that are upregulated in response to IFNα proteins (type I IFN response) compared with prostate cancer (TCGA-PRAD; Fig. 6C). This evidence concerns the gene IFNA1 and lung carcinoma.